Mayo Clinic
Subject: NO SUBJECT
Abstract
Summarizes PM's concern over, and strategies to address, IARC's multi-national study on ETS. Reports that "we are encouraging all PMI markets to step up proactive measures to preempt tough legislation tomorrow w/reasonable restrictions today. And we are also proposing that government adopt criteria for good epidemiology. If adopted by law or regulation these criteria would preclude governments from using the results of studies which don't meet the criteria. And most of the ETS studies to date do not." Requests that strategies be discussed with representatives of Japan Tobacco to "ensure JT regards the IARC threat and this strategy - among others - with the seriousness it deserves."
Fields
- Type
- Telex
- Company
- Philip Morris
- Site
- MN Depository
- Author
- Goodheart, Jan (PM Asia, Worldwide Regulatory Affairs Mgr.)Jan Goodheart was the Manager for Worldwide Regulatory Affairs for Philip Morris. (PMI's Introduction to Privilege Log and Glossary of Names, Estate of Burl Butler v. PMI, et al, April 19, 1996)
- Recipient
- Tilley, Karen
No images found for document.